Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | LTA · HBM Demand · Valuation Re-rating / 2026-05-27 Research
  • [IR] SK hynix (000660 / SKHY) – Q4 2024 Earnings Presentation / 2025-01-23 IR Room
  • [IR] Samsung Electronics (005930) – Q2 2025 Earnings Presentation / 2025-07-31 IR Room
  • [IR] Samsung Electronics (005930) – Q4 2023 Earnings Presentation / 2024-01-31 IR Room
  • [Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28 Research
  • [Research] LigaChem Biosciences (141080) – IBK Securities | Enhertu Resistance · Clinical Readouts · Tech Transfer / 2025-11-27 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · HBM4 · Valuation Appeal / 2026-07-30 Research

[Research] SK hynix (000660 / SKHY) – DS Investment | Server Memory Demand · HBM3E Pricing · Margin Expansion / 2026-01-30

Posted on January 30, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : DS Investment & Securities

Analyst : Surim Lee

Investment Rating : BUY (Maintained)

Target Price : 970,000 KRW (Raised)

Core Momentum : Strong server memory demand and tightening supply are expected to sustain pricing power across HBM and conventional memory, while rising HBM3E prices support continued margin expansion and earnings growth.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price: 970,000 KRW (Raised)
  • Investment Rating: BUY (Maintained)
  • 2026F Financial Outlook: Revenue 194.753 trillion KRW, Operating Profit 124.10 trillion KRW, Operating Margin 63.7%
  • EPS: 138,044 KRW (2026F)
  • Valuation Multiples: P/E 6.1x, P/B 3.0x, EV/EBITDA 3.7x (Based on 2026F)

🚀 2. [Market Opportunities & Business Outlook]

  • 4Q25 Review: Revenue reached 32.8 trillion KRW (+34% QoQ) and operating profit hit 19.2 trillion KRW (+68% QoQ, OPM 58%), breaking record highs. Estimated DRAM B/G +1%, ASP +24%; NAND B/G +11%, ASP +33%.
  • LTA & HBM Competitiveness: Long-Term Agreements (LTAs) are evolving into stronger formats amid solid server memory demand. HBM4 mass production is underway per schedule, targeting yields comparable to HBM3E via MR-MUF technology.
  • 1Q26 Preview: Operating profit is projected at 24.2 trillion KRW (+26% QoQ, OPM 62%). HBM3E prices are rising alongside tightening DDR5 supply and increasing ASIC client demand, while NAND ASP is expected to rise 20% QoQ.
  • Mid-to-Long-Term Strategy: Establishment of a US-based AI corporation aims to secure a partnership role within the AI data center ecosystem, with ongoing evaluation of shareholder return policies supported by earnings improvements.

📝 Editor’s Comment (Perspective)

The analyst views SK hynix as a company capturing stellar earnings growth and margin expansion, propelled by strong server memory demand and rising pricing power across HBM and legacy memory products. The analyst emphasizes near-term margin leverage and earnings growth driven by ASP increases.

To verify this investment thesis, one should monitor whether 1Q26 operating profit meets the projected 24 trillion KRW level (OPM 62%), if HBM3E price increases and HBM4 mass production proceed smoothly to safeguard profitability, and how the US AI entity unfolds its strategic role. These metrics can be tracked through upcoming quarterly earnings releases, official IR materials, and regulatory filings via DART/KRX.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] SK hynix (000660 / SKHY) – Kyobo | AI Server Demand · Memory ASP · High-Value Product Mix / 2026-01-30
Next Post: [Research] SK hynix (000660 / SKHY) – Hyundai Motor | Supply Shortage · Memory ASP · Profitability / 2026-01-30

Related Posts

  • [Research] Samsung SDI (006400) – Daishin Securities | Earlier Turnaround · North America ESS Expansion · LFP Order Pipeline / 2026-07-31 Research
  • [Research] LIG D&A (079550) – Hanwha Investment & Securities | 3Q25 Review · Secured Growth Materialization · Expanding Export Share / 2025-11-07 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | BBU Momentum · Hungarian Utilization Rebound · 2026 Operating Profit Turnaround / 2026-03-18 Research
  • [Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03 Research
  • [Research] Samsung SDI (006400) – Hanwha Investment & Securities | Delayed EV Recovery · ESS Highlights as Sole Driver · Target Price Cut / 2026-01-07 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | Supply Constraints · Memory Pricing · LTA / 2026-04-24 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Commodity DRAM Pricing · LTA · Multiple Expansion / 2026-06-26 Research
  • [Research] SK hynix (000660 / SKHY) – IBK Securities | AI Servers · Server DRAM · Supply Tightness / 2026-04-15 Research
  • [Research] Samsung Biologics (207940) – iM Securities | Annual Operating Profit Surpasses KRW 2T · Pure-CDMO Transition · Three-Pillar Growth Strategy / 2026-01-22 Research
  • [Research] Samsung Electro-Mechanics (009150) – DS Investment & Securities | MLCC Price Leverage · Capacity Cannibalization · Earnings Upward Revisions / 2026-07-31 Research
  • [Research] Celltrion (068270) – IBK Securities | New Biosimilar Mix Expansion · Operating Leverage · H2 Margin Expansion / 2026-05-07 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Capacity Cannibalization · 1-Year LTA · Pricing Power / 2026-07-06 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · LTA · Supply Tightness / 2026-04-23 Research
  • [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | Supply Shortage · High-End Mix · Earnings Upward Cycle / 2026-07-31 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme